References
Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415
Jeu L, Piacenti FJ, Lyakhovetskiy AG et al (2003) Voriconazole. Clin Ther 25:1321–1381
Saad AH, DePestel DD, Carver PL (2006) Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy 26:1730–1744
White WB, Duprez D, St Hillaire R et al (2003) Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 41:1021–1026
Kremens B, Brendel E, Bald M et al (1999) Loss of blood pressure control on withdrawal of fluconazole during nifedipine therapy. Br J Clin Pharmacol 47:707–708
Yu DT, Peterson JF, Seger DL et al (2005) Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf 14:755–767
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kato, J., Mori, T., Nakamura, Y. et al. Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine. Eur J Clin Pharmacol 65, 323–324 (2009). https://doi.org/10.1007/s00228-008-0588-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0588-1